Related Experiment Video
Updated: Jul 18, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Anti-angiogenic therapy for osteosarcoma
Gerald M Y Quan1, Peter F M Choong
1Department of Orthopaedics, University of Melbourne, St. Vincent's Hospital Melbourne, P O Box 2900, Fitzroy 3065, Australia.
Abstract:
Even in tumor centers using established protocols, the survival rate of patients with osteosarcoma has not improved significantly in recent years. Novel therapies are urgently needed as an adjunct to conventional treatment modalities, to reduce the dose and subsequent toxicity associated with current chemotherapy, improve local disease control, prevent development of metastases, and offer an alternative treatment for those tumors that are poorly responsive to chemotherapy. Anti-angiogenic therapy currently holds great potential in conjunction with conventional treatment modalities for osteosarcoma. Specifically, anti-angiogenic factors derived from cartilage, a natural barrier to osteosarcoma invasion, may have important therapeutic applications in osteosarcoma.
Insights
Novel therapies are needed for osteosarcoma, a bone cancer with stagnant survival rates. Cartilage-derived anti-angiogenic factors show promise as an adjunct to conventional treatments.
Area of Science:
- Oncology
- Biomedical Research
- Cancer Therapy
Background:
- Osteosarcoma survival rates have plateaued despite established treatment protocols.
- Conventional chemotherapy for osteosarcoma presents challenges including toxicity and limited efficacy in some cases.
- There is a critical need for novel therapeutic strategies to improve patient outcomes.
Purpose of the Study:
- To explore the potential of anti-angiogenic therapy as an adjunct treatment for osteosarcoma.
- To investigate cartilage-derived anti-angiogenic factors for therapeutic applications in osteosarcoma.
- To identify novel strategies to overcome limitations of current osteosarcoma treatments.
Main Methods:
- Review of existing literature on osteosarcoma treatment and anti-angiogenic therapies.
- Analysis of the role of cartilage as a natural barrier to tumor invasion.
- Exploration of the therapeutic potential of cartilage-derived anti-angiogenic factors.
Main Results:
- Anti-angiogenic therapy demonstrates significant potential when combined with conventional osteosarcoma treatments.
- Cartilage-derived factors possess anti-angiogenic properties relevant to inhibiting osteosarcoma progression.
- These factors may help reduce chemotherapy toxicity and combat metastatic disease.
Conclusions:
- Anti-angiogenic therapy, particularly using cartilage-derived factors, offers a promising avenue for improving osteosarcoma treatment.
- Further research into these factors could lead to more effective and less toxic therapeutic options.
- Targeting angiogenesis presents a viable strategy to enhance current osteosarcoma management.
